Stay updated with breaking news from Patrick Arbuthnot. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The announcement of a R3 billion pledge by SA-born biotech billionaire Dr Patrick Soon-Shiong, 68, to help South Africa in the fight against Covid-19 was a welcome shot in the arm for Covid-weary South Africans this week
The announcement of a R3 billion pledge by SA-born biotech billionaire Dr Patrick Soon-Shiong to help South Africa in the fight against Covid-19 was a welcome shot in the arm for Covid-weary South Africans this week
Wits partners with Biovac to develop skills that will help in producing vaccines By Chulumanco Mahamba Share Johannesburg - Wits University has partnered with Cape Town-based bio-pharmaceutical company Biovac to develop skills to produce viral vectored vaccines in South Africa. Wits University’s Antiviral Gene Therapy Research Unit (AGTRU), via Wits Enterprise, has joined with Cape Town-based bio-pharmaceutical company Biovac in partnership to develop the skills capacity to produce viral vectored vaccines. AGTRU has specialised expertise in advancing gene therapy for viral infections. Virus...
Tuesday 9 March 2021 - 11:00am Director of the antiviral gene therapy research unit at Wits, Professor Patrick Arbuthnot spoke with eNCA's Jane Dutton. Courtesy of #DStv403 JOHANNESBURG - Wits University has teamed up with the pharmaceutical company Biovac to reinforce the country's vaccine production capabilities. The collaboration will see viral-vectored vaccines being produced in South Africa. These vaccine types use the body' cells to develop antibodies to fight the virus. Patrick Arbuthnot said: "Basically the way it is working is that we have got experti...
8 March 2021 - Wits University The Antiviral Gene Therapy Research Unit via Wits Enterprise has partnered with Biovac to develop the skills capacity to produce viral vectored vaccines in SA. Demonstrating that South Africa has the capability and the skills resources to tackle serious health problems, Wits University’s Antiviral Gene Therapy Research Unit (AGTRU), with Wits Commercial Enterprise acting on its behalf, partnered with Cape Town based bio-pharmaceutical company, Biovac, in a partnership announced on 2 March 2021. Wits Enterprise is a private company wholly owned by Wits Un...